北京招聘

Location: Nanjing/China

Report to: Sr. Director of Downstream/Formulation Process Development

Key Responsibilities:

1. Lead formulation process development team for IND filing in China/US/EU or others

2. With experiences of up-to-date technology to develop robust formulation and scalable process

3. Well-experienced with China/US/EP regulation

4. Work with PM, CLD, CCPD, DSPD, AD team and QC/QA to draft the proposal, deliver the process, material and report

5. Communicate with clients to meet internal business goal and global regulation

6. Confirm the budget, material, timeline and capacity for multiple projects

7. Work independently and as a team player

8. Well-trained with GDP/GLP/GMP

9. Others duties assigned

Qualifications:

1. More than 5 years for Ph. D in Science/Engineer or more than 7 years for master degree of Biotech industry experiences

2. Able to analyze the analytical data for process development. Experience of pilot scale fill-finish is big plus

3. Mid management level experiences

4. Fluent both in English and Mandarin for writing and speaking

5. Good communication skill

6. Able to access and communicate risks, if necessary, develop and execute contingency plan

7. With IND filing experiences is plus

金斯瑞生物科技股份有限公司（股票代码HK01548）是全球化的生物科技集团公司。集团植根于领先的基因合成技术，核心业务范围已涵盖生物药开发与生产CDMO业务、细胞与基因治疗、生命科学服务及产品、生物酶及合成生物学产品四大领域。

金斯瑞成立于2002年，并于2015年在港交所主板挂牌上市。集团总部位于中国南京，运营实体遍布大中华区、北美区、欧洲区及亚太区，并以此为依托，为全球160多个国家和地区的10多万客户提供优质、便捷、可靠的服务与产品。

目前，金斯瑞在全球拥有超过3000名员工，其中34%以上的员工拥有硕士或博士学位。金斯瑞拥有多项知识产权及技术机密，其中包含100多项授权专利及270多项专利申请。截至2019年6月30日，有超过40,300篇经国际同业审阅的学术期刊文献引述了金斯瑞的服务及产品。

秉承“用生物技术使人和自然更健康”的企业使命，金斯瑞将一如既往地致力于成为最受信赖的生物科技公司。